The Next Phase of AI in Behavioral Health: Putting Clinical Judgment Back in Charge is starting in

Developments In Opioid Policy

Last week, we looked at the high number of opioid-analgesic poisoning deaths in the U.S. (see Drug-Related Deaths – Prescription Meds Still Top The List) – and how addressing prescription drug addiction will be increasingly important to improving population health and reducing health care costs. The problem is obviously getting attention – over the past 12 months, we have covered a number of related developments:

March 2015: The federal Department of Health and Human Services (HHS) announced new initiatives to increase the use of naloxone to reverse opioid overdoses, increase the use of medication-assisted opioid dependence treatment, and increase . . .

Want To Read More? Log In Or Become A Free Member
Resource Available For All OPEN MINDS Circle Members
If you are already a member, log in to your account to access this resource and more.

You can become a free member and get access now. Learn more about the OPEN MINDS Circle Market Intelligence Service Membership. Reach out to our team at info@openminds.com, or call us at 877-350-6463.

A Paid OPEN MINDS Circle Membership provides unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!